Lawsuits continue to mount against New England Compounding Pharmacy Inc. in the wake of a fungal meningitis outbreak linked to tainted single-dose vials of an injectable steroid produced by the company.
Several New Jersey residents, a Tennessee widow, a Michigan woman seeking to represent a nationwide class, and a Michigan couple recently sued the company, which does business as the New England Compounding Center (NECC), joining earlier litigants pursuing lawsuits over the allegedly contaminated steroid methylprednisolone acetate.
The new suits follow litigation by another Michigan woman, with fungal meningitis, and a Minnesota woman awaiting the results of medical testing, who ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.